Primary Care

Myositis

Questions discussed in this category

Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?

2 Answers available

How long do you maintain patients with anti-synthetase syndrome on Rituximab?

The patient was treated with two doses of Rituximab and on MMF. Now with stable lung function and normalized CK.

2 Answers available

How do you counsel patients with non-statin associated inflammatory myopathies about statin use?

1 Answer available

How do you manage calcium and vitamin D replacement in scleroderma and myositis patients with dysphagia and malabsorption?

1 Answer available

Is there any contraindication to the use of ezetimibe in patients with a history of statin induced necrotizing myopathy?

2 Answers available

How do you counsel young adults with antibody-negative necrotizing myopathy on prognosis and long-term monitoring/treatment?

How do you counsel young adults with antibody-negative necrotizing myopathy on prognosis, risk of recurrence, and long-term monitoring/treatment?

1 Answer available

How do you advise patients who had autoimmune diseases "triggered" by COVID infections on getting COVID vaccination?

E.g., inflammatory polyarthritis or inflammatory myopathy with onset within 2 weeks of documented COVID infection

1 Answer available

What would be your next step in management of a dermatomyositis patient on hydroxychloroquine and methotrexate whose skin is still active?

Muscle disease is quiescent and no other manifestations such as ILD

1 Answer available

Is it safe to use statins in IIM patients if HMGCR antibodies are negative?

1 Answer available

How long do you continue IVIG for myositis patients in remission on that therapy?

1 Answer available

Papers discussed in this category

Lancet Rheumatol, 2021 Apr 06

Incident systemic rheumatic disease following COVID-19.

N Engl J Med, 2020 Nov 20

Covid-19-Associated Myopathy Caused by Type I Interferonopathy.

Journal of clinical lipidology, 2008-10

Curr Rheumatol Rep, 2020 Aug 26

Lipid-lowering Therapies in Myositis.

Clinical and experimental immunology, 2015 Apr

Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study.

Medicine, 2021 Jan 08

Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study").

Curr Rheumatol Rep, 2023 Aug

Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use.

NeoReviews, 2021 Jan

Update on the Use of Intravenous Immunoglobulin in Pregnancy.

Journal of clinical pharmacology, 2023 Jun

Physiologic Changes During Pregnancy and Impact on Small-Molecule Drugs, Biologic (Monoclonal Antibody) Disposition, and Response.

Primary Care

Myositis

Questions discussed in this category

Papers discussed in this category

Related Topics in Primary Care